Alpha Cognition Inc (ACOG): Rega marang dodolan
Alpha Cognition management is focused on developing Alzheimer's disease therapies, which is reflected in the P/S volatility on the current GURU.Markets platform chart, where the value 9.30 serves as the baseline indicator. The company attracts biochemists through academic freedom and stock options, while its environmental strategy relies on laboratory safety and digitalization, establishing the foundation for future medical breakthroughs.
Alpha Cognition (ACOG) - rincian metrik lan laporan keuangan
- rega pasar lan target rega analis:
- data kapitalisasi bursa:
- data nilai buku modal saham:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal Alpha Cognition|ACOG - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal alphacognition.com|ACOG - Gunggung utang perusahaan|Utang-utang marang aset resik Alpha Cognition Corp|ACOG - Utang jangka dawa perusahaan|Utang jangka cendhak Alpha Cognition|Rasio likuiditas darurat alphacognition.com
- rincian bathi lan kelipatan pasar:
ACOG - Bathi resik|Proyeksi bathi mangsa ngarep Alpha Cognition|ACOG - Pangali P/E|Prakiraan rega marang bathi alphacognition.com|ACOG - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Alpha Cognition Corp|ACOG - Bathi operasional EBITDA|Bathi resik saben saham sajroning taun lumaku Alpha Cognition|ACOG - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan alphacognition.com|ACOG - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Alpha Cognition
- data total pendapatan lan volume dodolan:
Analisis umum perusahaan:ACOG, Alpha Cognition Inc
For Alpha Cognition (ACOG), which invests in upgrading measuring instruments and clinical trials for Alzheimer's drugs, monitoring the company's P/S ratio allows for an assessment of the business's market value relative to its annual sales. This ratio, illustrated on the chart, compares market capitalization with revenue, helping investors identify asset overvaluation or confirm the issuer's leadership by comparing current values with the historical trend.
Pesaing Alpha Cognition
Kapitalisasi marang pendapatan biogen.com BIIB|Rasio rega marang pendapatan Neurocrine Biosciences, Inc. NBIX|Regencell Bioscience Ltd (RGC) - Rega marang dodolan|Axsome Therapeutics Inc - Multiplikator P/S|Multiplikator rega marang pendapatan ACADIA Corp (ACAD)|Xenon Pharmaceuticals (XENE) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan VKTX|SUPN (Supernus) - Multiplikator P/S|Catalyst Pharma (CPRX) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan DNLI (Denali Therapeutics Inc)|Kapitalisasi marang volume dodolan HRMY|Multiplikator P/S BHVN (Biohaven Ltd.)|Koefisien rega marang pendapatan amylyx.com (AMLX)|TRVI - Rasio rega marang pendapatan|Rega marang dodolan Praxis Precision Medicines Inc|Anavex Corp (AVXL) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan CBLL|PRTA (Prothena Biosciences) - Multiplikator P/S|Multiplikator P/S Alector Therapeutics|Multiplikator P/S ANNX|Kapitalisasi marang pendapatan omeros.com OMER|Rasio rega marang pendapatan Neurogene Corp NGNE|AC Immune Inc (ACIU) - Rega marang dodolan|Voyager Therapeutics - Multiplikator P/S|Multiplikator rega marang pendapatan neumoratx.com (NMRA)|Scilex (SCLX) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan TVGN|CGTX (Cognition Therapeutics, Inc.) - Multiplikator P/S|Rega marang dodolan Inhibikase Pharma IKT|Kapitalisasi marang pendapatan SAVA (Cassava Sciences, Inc.)|Multiplikator P/S assertiotx.com (ASRT)|Rasio rega marang pendapatan Coya Therapeutics COYA|Rasio kapitalisasi pasar marang pendapatan VTGN|OVID - Rasio rega marang pendapatan|Rega marang dodolan Acumen Pharmaceuticals, Inc|CRVO: Multiplikator P/S|Alterity Therapeutics Limited (ATHE) - Multiplikator P/S|Rasio rega marang pendapatan Clene Inc|Rasio rega marang pendapatan PEPG|Rasio rega marang pendapatan Jupiter Neurosciences (JUNS)|RLMD: Rasio rega marang dodolan|Multiplikator P/S ANVS (Annovis Bio, Inc.)|Rasio kapitalisasi pasar marang pendapatan GRCE|Firefly Neuroscience - Multiplikator P/S|KLTO - Multiplikator P/S|NRSN (neurosense-tx.com) - Kapitalisasi marang pendapatan|Reviva Pharmaceuticals, Inc. - Rasio kapitalisasi pasar marang pendapatan|MTVA (MetaVia Inc.) - Multiplikator P/S|Kapitalisasi marang pendapatan neuraxis.com (NRXS)|Rasio rega marang pendapatan Helius Medical (HSDT)|PASG - Rega marang dodolan|Multiplikator P/S NEUP (Neuphoria Therapeutics)|Multiplikator rega marang pendapatan Minerva|ATHA - Rasio rega marang pendapatan|ADXN (addextherapeutics.com) - Rasio kapitalisasi marang pendapatan|ALZN: Multiplikator P/S|CYCN - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan PTIX|KTTA (Pasithea) - Kapitalisasi marang volume dodolan|Multiplikator P/S CRGT|Koefisien rega marang pendapatan avenuetx.com|Rasio rega marang pendapatan BrainStorm Cell Therapeutics BCLI|Cara Therapeutics Inc. (CARA) - Rega marang dodolan|CHRO - Rasio rega marang pendapatan|ELYM (Eliem Therapeutics) - Rasio kapitalisasi marang pendapatan|ITCI: Multiplikator P/S|longboardpharma.com (LBPH) - Multiplikator P/S|MRNS (Marinus Pharmaceuticals, Inc.) - Multiplikator P/S|Kapitalisasi marang pendapatan NKGen Biotech Inc (NKGN)|Rasio rega marang pendapatan NeuroBo (NRBO)|SAGE - Rega marang dodolan|Multiplikator P/S SNPX (Synaptogenix, Inc.)|Multiplikator rega marang pendapatan trevena.com|VIGL - Rasio rega marang pendapatan|WENA (anewmeds.com) - Rasio kapitalisasi marang pendapatan|CERE: Multiplikator P/S
